Tue, May 6, 11:40 AM (17 days ago)
**Bioventus Inc. (BVS) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $123.9 million, down 4.3% YoY due to divestiture of Advanced Rehabilitation Business. - **Gross Profit:** $83.1 million, down 6.0% YoY, with gross margins at 67.0%. - **Operating Income:** $4.9 million, up 1.4% YoY. - **Net Loss:** $3.3 million, improved from $6.4 million YoY. - **Adjusted EBITDA:** $19.2 million, down 15.1% YoY. **Profit Margins:** - **Gross Margin:** 67.0%, down from 68.3% YoY. - **Operating Margin:** 3.9%, up from 3.8% YoY. **Cash Flow:** - **Net Cash from Operating Activities:** -$19.3 million, down from -$6.0 million YoY. - **Net Cash from Investing Activities:** -$0.8 million, improved from -$1.0 million YoY. - **Net Cash from Financing Activities:** $0.9 million, up from -$4.2 million YoY. **Earnings Changes:** - **EPS (Basic & Diluted):** -$0.04, improved from -$0.08 YoY. **Quarterly Performance Discussion:** - **Revenue Decline:** Primarily due to the divestiture of the Advanced Rehabilitation Business, which impacted both U.S. and International segments. - **Cost Management:** Selling, general, and administrative expenses decreased by 6.7% YoY. - **Research & Development:** Increased by 14.6% YoY due to equity-based compensation forfeitures. - **Interest Expense:** Decreased by 27.4% YoY due to less debt outstanding and lower interest rates. **Trends & Uncertainties:** - **Divestiture Impact:** The sale of the Advanced Rehabilitation Business reduced revenue but improved liquidity. - **Legal Proceedings:** Ongoing shareholder litigation may impact financials and management focus. - **Future Operations:** Focus on core businesses and potential acquisitions or divestitures to improve liquidity. **Future Operations Impact:** - **Liquidity:** Bioventus expects sufficient liquidity for the next 12 months, with potential additional funding through equity, debt, or asset sales. - **Debt Management:** Compliance with financial covenants under the Amended 2019 Credit Agreement. - **Growth Strategies:** Expansion into international markets and development of new products. **Ticker:** BVS